|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
29 August 2022 |
|
Main ID: |
NCT03813160 |
|
Date of registration:
|
21/01/2019 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
DETERMINE |
|
Scientific title:
|
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis |
|
Date of first enrolment:
|
December 17, 2018 |
|
Target sample size:
|
176 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT03813160 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
|
|
Phase:
|
Phase 3
|
|
|
Countries of recruitment
|
|
Bulgaria
|
Canada
|
Czechia
|
Germany
|
Hungary
|
Italy
|
Japan
|
Korea, Republic of
|
|
Poland
|
Spain
|
Sweden
|
Switzerland
|
United Kingdom
|
United States
| | |
|
Contacts
|
|
Name:
|
Chester V Oddis, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Pittsburgh Department of Medicine/Division of Rheumatology |
|
|
Name:
|
Victoria P Werth, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Pennsylvania |
| |
|
Key inclusion & exclusion criteria
|
|
Health Condition(s) or Problem(s) studied
|
|
Source(s) of Monetary Support
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|